Comparative Assessment of E-cadherin’s Expression between the Metastatic and Non-metastatic Oral Squamous Cell Carcinoma: An Immunohistochemical Study

Sufia Khan; Veda Hegde; Deepti Shrivastava; Mohammed Azamulla; Mohammad Khursheed Alam; Kumar Chandan Srivastava

Authors

Sufia Khan
Veda Hegde
Deepti Shrivastava
Mohammed Azamulla
Mohammad Khursheed Alam
Kumar Chandan Srivastava

Keywords:

Cadherins, Cell Adhesion, Squamous Cell Carcinoma of Head and Neck, Neoplasm Metastasis

Abstract

Objective: To identify the clinicopathological correlation of E-cadherin expression in metastatic and non-metastatic oral squamous cell carcinoma (OSCC). Material and Methods: A total of 90 paraffin-embedded tissue sections of OSCC were retrieved from the registry. The total selected samples were 45 cases each from the primary lesions of metastatic and non-metastatic OSCC. One section was subjected to routine Hematoxylin and eosin stain and another to immunohistochemical analysis for E-cadherin expression. Results: A non-significant (p˃0.05) increased expression is seen in the non-metastatic group compared to the metastatic group, with predominantly membrane as the staining site in either group. However, the expression of E-cadherin did not reveal any statistically significant association with independent variables such as age, gender, and adverse habits of the patients (p>0.05). On the other hand, with respect to the histological differentiation of OSCC, a significant association (p<0.001) was observed with the well-differentiated type of metastatic OSCC. Conclusion: E-cadherin was useful to some extent in predicting regional metastasis. However, further studies using a panel of biomarkers with increased sample size may help us understand the process involved in metastasis.

References

Maître JL, Heisenberg CP. Three functions of cadherins in cell adhesion. Curr Biol 2013; 23(14):R626-33. https://doi.org/10.1016/j.cub.2013.06.019

Harjunpää H, Llort Asens M, Guenther C, Fagerholm SC. Cell adhesion molecules and their roles and regulation in the immune and tumor microenvironment. Front Immunol 2019; 10:1078. https://doi.org/10.3389/fimmu.2019.01078

Ren G, Roberts AI, Shi Y. Adhesion molecules: key players in Mesenchymal stem cell-mediated immunosuppression. Cell Adh Migr 2011; 5(1):20-2. https://doi.org/10.4161/cam.5.1.13491

Bagutti C, Speight PM, Watt FM. Comparison of integrin, cadherin, and catenin expression in squamous cell carcinomas of the oral cavity. J Pathol 1998; 186(1):8-16.

Balasundaram P, Singh MK, Dinda AK, Thakar A, Yadav R. Study of β-catenin, E-cadherin and vimentin in oral squamous cell carcinoma with and without lymph node metastases. Diagn Pathol 2014; 9:145. https://doi.org/10.1186/1746-1596-9-145

Ramos-García P, González-Moles MÁ. Prognostic and clinicopathological significance of the aberrant expression of β-catenin in oral squamous cell carcinoma: a systematic review and meta-analysis. Cancers 2022; 14(3):479. https://doi.org/10.3390/cancers14030479

Behrens J, Vakaet L, Friis R, Winterhager E, Van Roy F, Mareel MM, et al. Loss of epithelial differentiation and gain of invasiveness correlates with tyrosine phosphorylation of the E-cadherin/beta-catenin complex in cells transformed with a temperature-sensitive v-SRC gene. J Cell Biol 1993; 120(3):757-66. https://doi.org/10.1083/jcb.120.3.757

Choi W, Porten S, Kim S, Willis D, Plimack ER, Hoffman-Censits J, et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell 2014; 25(2):152-65. https://doi.org/10.1016/j.ccr.2014.01.009

Doğan A, Wang ZD, Spencer J. E-cadherin expression in intestinal epithelium. J Clin Pathol 1995; 48(2):143-6. https://doi.org/10.1136/jcp.48.2.143

Kim HN, Ruan Y, Ogana H, Kim YM. Cadherins, selectins, and integrins in CAM-DR in leukemia. Front Oncol 2020; 10:592733. https://doi.org/10.3389/fonc.2020.592733

Field JK. Oncogenes and tumour suppressor genes in squamous cell carcinoma of the head and neck. Eur J Cancer B Oral Oncol 1992; 28B(1):67-76. https://doi.org/10.1016/0964-1955(92)90016-t

Kaur G, Carnelio S, Rao N, Rao L. Expression of E-cadherin in primary oral squamous cell carcinoma and metastatic lymph nodes: An immunohistochemical study. Indian J Dent Res 2009; 20(1):71-6. https://doi.org/10.4103/0970-9290.49075

Kowalski PJ, Rubin MA, Kleer CG. E-cadherin expression in primary carcinomas of the breast and its distant metastases. Breast Cancer Res 2003; 5(6):R217-22. https://doi.org/10.1186/bcr65

Gall TM, Frampton AE. Gene of the month: E-cadherin (CDH1). J Clin Pathol 2013; 66(11):928-32. https://doi.org/10.1136/jclinpath-2013-201768

Gottardi CJ, Gumbiner BM. Adhesion signaling: how β-catenin interacts with its partners. Current boil 2001; 11(19):R792-4. https://doi.org/10.1016/s0960-9822(01)00473-0

Pećina-Šlaus N. Tumor suppressor gene E-cadherin and its role in normal and malignant cells. Cancer Cell Int 2003; 3(1):1-7. https://doi.org/10.1186/1475-2867-3-17

Srivastava KC. Comparative evaluation of saliva’s oxidant–antioxidant status in patients with different clinicopathological types of oral leukoplakia. J Int Soc Prev Community Dent 2019; 9(4):396-402. https://doi.org/10.4103/jispcd.JISPCD_179_19

Srivastava KC, Austin RD, Shrivastava D. Evaluation of oxidant-antioxidant status in tissue samples in oral cancer: a case control study. Dent Res J 2016; 13(2):181-7. https://doi.org/10.4103/1735-3327.178210

Sung H, Ferlay J, Siegel RL, Laversanne M, Soerjomataram I, Jemal A, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71(3):209-49. https://doi.org/10.3322/caac.21660

Hedrick L, Cho KR, Vogelstein B. Cell adhesion molecules as tumour suppressors. Trends Cell Biol 1993; 3(2):36-9. https://doi.org/10.1016/0962-8924(93)90148-t

Huber GF, Zullig L, Soltermann A, Roessle M, Graf N, Haerle SK, et al. Down-regulation of E-cadherin (ECAD) - a predictor for occult metastatic disease in sentinel node biopsy of early squamous cell carcinomas of the oral cavity and oropharynx. BMC Cancer 2011; 11(217):211-8. https://doi.org/10.1186/1471-2407-11-217

Downer CS, Speight PM. E-cadherin expression in normal, hyperplastic and malignant oral epithelium. Eur J Cancer B Oral Oncol 1993; 29B(4):303-5. https://doi.org/10.1016/0964-1955(93)90053-h

Freemont AJ. Demystified adhesion molecules. Mol Pathol 1998; 51(4):175–84. https://doi.org/10.1136/mp.51.4.175

Myong NH. Loss of E-cadherin and acquisition of vimentin in epithelial-mesenchymal transition are noble indicators of uterine cervix cancer progression. Korean J Pathol 2012; 46(4):341-8. https://doi.org/10.4132/KoreanJPathol.2012.46.4.341

Hung KF, Chang CS, Liu CJ, Lui MT, Cheng CY, Kao SY. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma. J Oral Pathol Med 2006; 35:589-94. https://doi.org/10.1111/j.1600-0714.2006.00474.x

Tanaka N, Odajima T, Ogi K, Ikeda T, Satoh M. Expression of E-cadherin, alpha-catenin, and beta-catenin in the process of lymph node metastasis in oral squamous cell carcinoma. Br J Cancer 2003; 89:557-63. https://doi.org/10.1038/sj.bjc.6601124

Sterlacci W, Fiegl M, Hilbe W, Jamnig H, Oberaigner W, Schmid T, et al. Deregulation of p27 and cyclin D1/D3 control over mitosis is associated with unfavorable prognosis in non-small cell lung cancer, as determined in 405 operated patients. J Thorac Oncol 2010; 5(9):1325-36. https://doi.org/10.1097/JTO.0b013e3181e77efc

Yazdani J, Ghavimi MA, Jabbari Hagh E, Ahmadpour F. The role of E-cadherin as a prognostic biomarker in head and neck squamous carcinoma: a systematic review and meta-analysis. Mol Diagn Ther 2018; 22(5):523-35. https://doi.org/10.1007/s40291-018-0351-y

Luo SL, Xie YG, Li Z, Ma JH, Xu X. E-cadherin expression and prognosis of oral cancer: a meta-analysis. Tumour Biol 2014; 35(6):5533-7. https://doi.org/10.1007/s13277-014-1728-0